Frontiers in Aging Neuroscience, 2022 · DOI: 10.3389/fnagi.2022.963539 · Published: December 7, 2022
Spinal cord injury (SCI) often leads to permanent neurological issues, especially in older individuals, due to the body's limited ability to repair nerve damage in the injured area. Traditionally, the immune system's role after SCI was underestimated, but recent research shows that the central nervous system (CNS) actively uses immune responses for both harm and repair. Therefore, it's crucial to deeply understand the immune environment after SCI to develop better treatments that support tissue repair and nerve recovery.
Understanding the specific roles of immune cells and molecules post-SCI can lead to targeted immunotherapies to promote tissue repair and neurological recovery.
Targeting drug delivery to the lesion site with nanotechnologies can enhance the effectiveness of immunomodulatory treatments by overcoming the blood-spinal cord barrier.
Addressing gut dysbiosis with probiotics or fecal microbiota transplantation can improve systemic immune function and support SCI recovery.